Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

277 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Plasma DNA integrity as a biomarker for primary and metastatic breast cancer and potential marker for early diagnosis.
Madhavan D, Wallwiener M, Bents K, Zucknick M, Nees J, Schott S, Cuk K, Riethdorf S, Trumpp A, Pantel K, Sohn C, Schneeweiss A, Surowy H, Burwinkel B. Madhavan D, et al. Among authors: burwinkel b. Breast Cancer Res Treat. 2014 Jul;146(1):163-74. doi: 10.1007/s10549-014-2946-2. Epub 2014 May 17. Breast Cancer Res Treat. 2014. PMID: 24838941
Association of NCOA3 polymorphisms with breast cancer risk.
Burwinkel B, Wirtenberger M, Klaes R, Schmutzler RK, Grzybowska E, Försti A, Frank B, Bermejo JL, Bugert P, Wappenschmidt B, Butkiewicz D, Pamula J, Pekala W, Zientek H, Mielzynska D, Siwinska E, Bartram CR, Hemminki K. Burwinkel B, et al. Clin Cancer Res. 2005 Mar 15;11(6):2169-74. doi: 10.1158/1078-0432.CCR-04-1621. Clin Cancer Res. 2005. PMID: 15788663
c-MYC Asn11Ser is associated with increased risk for familial breast cancer.
Wirtenberger M, Hemminki K, Försti A, Klaes R, Schmutzler RK, Grzybowska E, Bermejo JL, Wappenschmidt B, Bugert P, Butkiewicz D, Pamula J, Pekala W, Zientek H, Bartram CR, Burwinkel B. Wirtenberger M, et al. Among authors: burwinkel b. Int J Cancer. 2005 Nov 20;117(4):638-42. doi: 10.1002/ijc.21225. Int J Cancer. 2005. PMID: 15929079
TP53-binding protein variants and breast cancer risk: a case-control study.
Frank B, Hemminki K, Bermejo JL, Klaes R, Bugert P, Wappenschmidt B, Schmutzler RK, Burwinkel B. Frank B, et al. Among authors: burwinkel b. Breast Cancer Res. 2005;7(4):R502-5. doi: 10.1186/bcr1038. Epub 2005 May 6. Breast Cancer Res. 2005. PMID: 15987456 Free PMC article.
The CASP8 -652 6N del promoter polymorphism and breast cancer risk: a multicenter study.
Frank B, Rigas SH, Bermejo JL, Wiestler M, Wagner K, Hemminki K, Reed MW, Sutter C, Wappenschmidt B, Balasubramanian SP, Meindl A, Kiechle M, Bugert P, Schmutzler RK, Bartram CR, Justenhoven C, Ko YD, Brüning T, Brauch H, Hamann U, Pharoah PP, Dunning AM, Pooley KA, Easton DF, Cox A, Burwinkel B. Frank B, et al. Among authors: burwinkel b. Breast Cancer Res Treat. 2008 Sep;111(1):139-44. doi: 10.1007/s10549-007-9752-z. Epub 2007 Sep 21. Breast Cancer Res Treat. 2008. PMID: 17891485
A genetic variant in the pre-miR-27a oncogene is associated with a reduced familial breast cancer risk.
Yang R, Schlehe B, Hemminki K, Sutter C, Bugert P, Wappenschmidt B, Volkmann J, Varon R, Weber BH, Niederacher D, Arnold N, Meindl A, Bartram CR, Schmutzler RK, Burwinkel B. Yang R, et al. Among authors: burwinkel b. Breast Cancer Res Treat. 2010 Jun;121(3):693-702. doi: 10.1007/s10549-009-0633-5. Epub 2009 Nov 18. Breast Cancer Res Treat. 2010. PMID: 19921425
277 results